glutathione for ckd Is appropriate patients with chronic kidney disease, and if so, what oral dose and monitoring are recommended? Why glutathione isn't the antidote

Mechanistically, GLPs exert renoprotective effects by suppressing the PI3K/Akt/mTOR signaling cascade, promoting autophagicevidenced by increased Beclin-1 expression and LC3-II/LC3-I ratio, along with decreased p62 accumulationwhile simultaneously attenuating apoptotic activity (reducing caspase-3 and caspase-9 levels) and dampening pro-inflammatory responses (lowering IL-6, IL-1, and TNF-)

Symptoms of hypoglycemia include shakiness, sweating, confusion, rapid heartbeat, and in severe cases, loss of consciousness

Reported adverse events were minor and transient

Copper peptides are more about communication and support